Changes in Doppler Signals From the Lung Due to Cardiac Resynchronization in Heart Failure Patients
Lung Doppler Signals Changes in Response to Cardiac Resynchronization in Heart Failure Patients
1 other identifier
observational
10
1 country
1
Brief Summary
Study Purpose and Rationale The purpose of this study is to evaluate the lung Doppler signals changes during cardiac resynchronization procedure. As the LDS represent the various mechanical events of cardiac origin it is assumed that they may reflect the relative timing between contraction of the ventricles and atria and thus serve for effective synchronization of these activities. Aim of the study: The aim of the study is to assess whether the changes in Lung Doppler Signal (LDS) waves' characteristics will mimic the changes in echocardiographic parameters designed to assess diastolic inflow and systolic flow in patients undergoing Echo-based CRT optimization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2014
CompletedFirst Posted
Study publicly available on registry
July 1, 2014
CompletedStudy Start
First participant enrolled
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedAugust 13, 2015
June 1, 2014
1.1 years
June 27, 2014
August 12, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Doppler signals before and after CRT
During procedure
Eligibility Criteria
Patients with indication for cardiac snchronization therapy
You may qualify if:
- Male and female patients 18 years or older, who met the indications for cardiac synchronization therapy (CRT) per the ACCF/AHA guidelines, underwent successful system implant for more than 3 months, and were referred to the CRT non-responder clinic at the Ohio State University for CRT- Echo optimization due to absence of clinical improvement in functional class or ejection fraction after the implant per the judgment of the referring physician.
You may not qualify if:
- Chronic atrial fibrillation or new cardiac arrhythmias detected at the time of the visit that are known to affect the response to CRT (Atrial fibrillation, supraventricular tachycardia, ventricular tachycardia, or frequent premature ventricular contractions).
- CRT device malfunction
- Inadequate CRT programming that has contributed to lack of response to CRT
- Coronary sinus lead anatomical or electrical malfunctions at the time of the visit
- Acute systemic illness that can explain their lack of functional improvement (i.e., anemia, severe electrolyte imbalance, pneumothorax, pericardial effusion, pneumonia)
- Inability to sign informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Echosense Ltd.lead
Study Sites (1)
The Ohio State University 473 West 12th Ave.
Columbus, Ohio, 43210, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Hyesha Hasan, MD
Ohio State University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 27, 2014
First Posted
July 1, 2014
Study Start
July 1, 2014
Primary Completion
August 1, 2015
Study Completion
August 1, 2015
Last Updated
August 13, 2015
Record last verified: 2014-06